These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 34341786)

  • 1. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation.
    Venzon M; Bernard-Raichon L; Klein J; Axelrad JE; Hussey GA; Sullivan AP; Casanovas-Massana A; Noval MG; Valero-Jimenez AM; Gago J; Wilder E; ; Thorpe LE; Littman DR; Dittmann M; Stapleford KA; Shopsin B; Torres VJ; Ko AI; Iwasaki A; Cadwell K; Schluter J
    Res Sq; 2021 Jul; ():. PubMed ID: 34341786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut microbiome dysbiosis during COVID-19 is associated with increased risk for bacteremia and microbial translocation.
    Venzon M; Bernard-Raichon L; Klein J; Axelrad JE; Zhang C; Hussey GA; Sullivan AP; Casanovas-Massana A; Noval MG; Valero-Jimenez AM; Gago J; Putzel G; Pironti A; Wilder E; ; Thorpe LE; Littman DR; Dittmann M; Stapleford KA; Shopsin B; Torres VJ; Ko AI; Iwasaki A; Cadwell K; Schluter J
    bioRxiv; 2022 Mar; ():. PubMed ID: 35262080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiome dysbiosis in antibiotic-treated COVID-19 patients is associated with microbial translocation and bacteremia.
    Bernard-Raichon L; Venzon M; Klein J; Axelrad JE; Zhang C; Sullivan AP; Hussey GA; Casanovas-Massana A; Noval MG; Valero-Jimenez AM; Gago J; Putzel G; Pironti A; Wilder E; ; Thorpe LE; Littman DR; Dittmann M; Stapleford KA; Shopsin B; Torres VJ; Ko AI; Iwasaki A; Cadwell K; Schluter J
    Nat Commun; 2022 Nov; 13(1):5926. PubMed ID: 36319618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 infection is associated with intestinal permeability, systemic inflammation, and microbial dysbiosis in hospitalized patients.
    Basting CM; Langat R; Broedlow CA; Guerrero CR; Bold TD; Bailey M; Velez A; Schroeder T; Short-Miller J; Cromarty R; Mayer ZJ; Southern PJ; Schacker TW; Safo SE; Bramante CT; Tignanelli CJ; Schifanella L; Klatt NR
    Microbiol Spectr; 2024 Sep; ():e0068024. PubMed ID: 39345212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of gut microbiota with the pathogenesis of SARS-CoV-2 Infection in people living with HIV.
    Ishizaka A; Koga M; Mizutani T; Yamayoshi S; Iwatsuki-Horimoto K; Adachi E; Suzuki Y; Kawaoka Y; Yotsuyanagi H
    BMC Microbiol; 2024 Jan; 24(1):6. PubMed ID: 38172680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysbiosis of Oral and Gut Microbiomes in SARS-CoV-2 Infected Patients in Bangladesh: Elucidating the Role of Opportunistic Gut Microbes.
    Rafiqul Islam SM; Foysal MJ; Hoque MN; Mehedi HMH; Rob MA; Salauddin A; Tanzina AY; Biswas S; Noyon SH; Siddiki AMAMZ; Tay A; Mannan A
    Front Med (Lausanne); 2022; 9():821777. PubMed ID: 35237631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gut bacterial dysbiosis and instability is associated with the onset of complications and mortality in COVID-19.
    Schult D; Reitmeier S; Koyumdzhieva P; Lahmer T; Middelhoff M; Erber J; Schneider J; Kager J; Frolova M; Horstmann J; Fricke L; Steiger K; Jesinghaus M; Janssen KP; Protzer U; Neuhaus K; Schmid RM; Haller D; Quante M
    Gut Microbes; 2022; 14(1):2031840. PubMed ID: 35174781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signatures of COVID-19 Severity and Immune Response in the Respiratory Tract Microbiome.
    Merenstein C; Liang G; Whiteside SA; Cobián-Güemes AG; Merlino MS; Taylor LJ; Glascock A; Bittinger K; Tanes C; Graham-Wooten J; Khatib LA; Fitzgerald AS; Reddy S; Baxter AE; Giles JR; Oldridge DA; Meyer NJ; Wherry EJ; McGinniss JE; Bushman FD; Collman RG
    mBio; 2021 Aug; 12(4):e0177721. PubMed ID: 34399607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of COVID-19 and Antibiotic Treatments on Gut Microbiome: A Role for
    Righi E; Lambertenghi L; Gorska A; Sciammarella C; Ivaldi F; Mirandola M; Sartor A; Tacconelli E
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization.
    Zuo T; Zhang F; Lui GCY; Yeoh YK; Li AYL; Zhan H; Wan Y; Chung ACK; Cheung CP; Chen N; Lai CKC; Chen Z; Tso EYK; Fung KSC; Chan V; Ling L; Joynt G; Hui DSC; Chan FKL; Chan PKS; Ng SC
    Gastroenterology; 2020 Sep; 159(3):944-955.e8. PubMed ID: 32442562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gut microbiome alterations and gut barrier dysfunction are associated with host immune homeostasis in COVID-19 patients.
    Sun Z; Song ZG; Liu C; Tan S; Lin S; Zhu J; Dai FH; Gao J; She JL; Mei Z; Lou T; Zheng JJ; Liu Y; He J; Zheng Y; Ding C; Qian F; Zheng Y; Chen YM
    BMC Med; 2022 Jan; 20(1):24. PubMed ID: 35045853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma Microbiome in COVID-19 Subjects: An Indicator of Gut Barrier Defects and Dysbiosis.
    Prasad R; Patton MJ; Floyd JL; Fortmann S; DuPont M; Harbour A; Wright J; Lamendella R; Stevens BR; Oudit GY; Grant MB
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of the gut microbiome in colonization resistance and recurrent
    Seekatz AM; Safdar N; Khanna S
    Therap Adv Gastroenterol; 2022; 15():17562848221134396. PubMed ID: 36425405
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19.
    Yeoh YK; Zuo T; Lui GC; Zhang F; Liu Q; Li AY; Chung AC; Cheung CP; Tso EY; Fung KS; Chan V; Ling L; Joynt G; Hui DS; Chow KM; Ng SSS; Li TC; Ng RW; Yip TC; Wong GL; Chan FK; Wong CK; Chan PK; Ng SC
    Gut; 2021 Apr; 70(4):698-706. PubMed ID: 33431578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 infection, gut dysbiosis, and heterogeneous clinical results of hydroxychloroquine on COVID-19 therapy-Is there a link?
    Balmant BD; Torrinhas RS; Rocha IM; Fonseca DC; Formiga FFC; Bonfá ESDO; Borba EF; Waitzberg DL
    Nutrition; 2021 May; 85():111115. PubMed ID: 33545540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporal dynamics of oropharyngeal microbiome among SARS-CoV-2 patients reveals continued dysbiosis even after Viral Clearance.
    Paine SK; Rout UK; Bhattacharyya C; Parai D; Alam M; Nanda RR; Tripathi D; Choudhury P; Kundu CN; Pati S; Bhattacharya D; Basu A
    NPJ Biofilms Microbiomes; 2022 Aug; 8(1):67. PubMed ID: 36002454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SARS-CoV-2 infection alters the gut microbiome in diabetes patients: A cross-sectional study from Bangladesh.
    Mannan A; Hoque MN; Noyon SH; Mehedi HMH; Foysal MJ; Salauddin A; Islam SMR; Sharmen F; Tanni AA; Siddiki AZ; Tay A; Siddique MM; Rahman MS; Galib SM; Akter F
    J Med Virol; 2023 Apr; 95(4):e28691. PubMed ID: 36946508
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gut Microbiome Alterations in COVID-19.
    Zuo T; Wu X; Wen W; Lan P
    Genomics Proteomics Bioinformatics; 2021 Oct; 19(5):679-688. PubMed ID: 34560321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Additional
    Panpetch W; Hiengrach P; Nilgate S; Tumwasorn S; Somboonna N; Wilantho A; Chatthanathon P; Prueksapanich P; Leelahavanichkul A
    Gut Microbes; 2020 May; 11(3):465-480. PubMed ID: 31530137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.